Enzo Posts Strong Q1 Revenue and Income; Exec Hints Trend May Not Last

Dec 16, 2002

NEW YORK, Dec. 16 - Enzo Biochem today reported strong first-quarter revenue growth atop an increase in R&D spending and a jump in net income. However, a top executive hinted the results were largely due to "unusually strong"--yet short-lived--demand.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

This Week in Nucleic Acids Research

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

Round and Round We Go

A BMJ study says that about half of former hematology-oncology regulators now work for industry.

Goodbye and Godspeed

Science should wish PhDs who leave academia well, a Nature editorial says.

New Baby Boy

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.

Main menu